Registered Kenya · PPB

TROXAKEL INJECTABLE SOLUTION

NITROXINIL

V2008/18453/006 340MG

What it does

Nitroxinil is a medication used to treat certain parasitic infections in animals.

Commonly used for: parasitic infections in livestock, helminthiasis (worm infections)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
V2008/18453/006
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
NITROXINIL
Dosage form
340MG
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Medina Chemicals
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
ICD ROAD , OPPOSITE HIFADHI HOUSE, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 22:10:57 · updated 2026-03-23 04:56:15

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Nitroxinil is a medication used to treat certain parasitic infections in animals.

What it treats

  • parasitic infections in livestock
  • helminthiasis (worm infections)

How it works

Nitroxinil works by killing parasites and helping to clear the infection from the body.

Who it's for

Nitroxinil is primarily for use in animals, particularly livestock, to treat infections caused by parasites.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: nitroxinil

BNF-referenced

Nitroxinil is an anthelmintic agent primarily used for the treatment of parasitic infections, particularly in livestock. It is effective against various species of gastrointestinal nematodes and some cestodes. Nitroxinil is also used in veterinary medicine for its efficacy in treating infections caused by flukes and roundworms.

Indications

  • Gastrointestinal nematode infections
  • Cestode infections
  • Liver fluke infections

Dosage

Children: Refer to the BNF for Children for specific dosage guidelines in paediatric patients.

Adults: Refer to the BNF for specific dosage recommendations based on the condition being treated.

Mechanism of action

Nitroxinil acts by inhibiting energy metabolism in helminths, affecting their ability to maintain homeostasis. It interferes with the parasite's mitochondrial function, leading to depletion of ATP and eventual death of the parasite. This mechanism primarily targets the parasites' energy production pathways.

Pharmacodynamics

Nitroxinil exhibits selective toxicity towards helminths due to differences in mitochondrial biochemistry between the parasites and host cells. Its action leads to paralysis and death of the parasites, facilitating their expulsion from the host organism.

Pharmacokinetics

Nitroxinil is absorbed in the gastrointestinal tract following oral administration, with peak plasma concentrations occurring within a few hours. It is metabolized in the liver, and its metabolites are primarily excreted through the urine and feces. The drug has a relatively short half-life, necessitating multiple doses for sustained therapeutic effect.

Pregnancy

There is limited data on the use of nitroxinil during pregnancy. Caution is advised, and it should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether nitroxinil is excreted in human milk. Caution is recommended when administering to nursing mothers.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: nitroxinil

PubChem CID 15532

Molecular formula: C7H3IN2O3

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.